| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5K | -74.4% |
| Cost of Revenue | $31K | +21.3% |
| Gross Profit | -$3K | +50.6% |
| R&D Expense | $325K | -55.7% |
| SG&A Expense | $242K | +45.9% |
| Operating Income | -$2.6M | +6.8% |
| Pre-tax Income | -$2.9M | -0.5% |
| Net Income | -$2.9M | -0.5% |
| EPS (Basic) | -$0.01 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.2M | +39.0% |
| Accounts Receivable | $10K | +47.5% |
| Current Assets | $2.2M | +38.7% |
| Total Assets | $2.2M | +38.7% |
| Current Liabilities | $86K | -64.8% |
| Total Liabilities | $86K | -64.8% |
| Stockholders' Equity | $2.1M | +57.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.7M | -30.2% |
| Financing Cash Flow | $2.3M | +95.4% |
| +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |